Doxorubicin/ifosfamide/mesnaLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72627-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：190 / 190

相关论文

共 50 条

[21] Doxorubicin/ifosfamide/pegfilgrastimVarious toxicities: case report
Reactions Weekly, 2020, 1834 (1) : 102 - 102
[22] Doxorubicin/ifosfamide/vincristineNausea and neutropenia: case report
Reactions Weekly, 2016, 1603 (1) : 109 - 109
[23] Doxorubicin/ifosfamide/mesnaWound complication: case report
Reactions Weekly, 2017, 1677 (1) : 122 - 122
[24] Doxorubicin/ifosfamide/mesnaNeutropenic fever: case report
Reactions Weekly, 2021, 1837 (1) : 223 - 223
[25] AntineoplasticsSarcoma (first report with cisplatin, doxorubicin and ifosfamide): case report
Reactions Weekly, 2007, 1168 (1) : 6 - 7
[26] Ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1887 (1) : 371 - 371
[27] Ifosfamide/methotrexateLack of efficacy: case report
Reactions Weekly, 2021, 1852 (1) : 221 - 221
[28] Doxorubicin/ifosfamide/mesnaFatal neutropenic fever and sepsis: case report
Reactions Weekly, 2019, 1754 (1) : 138 - 138
[29] Cisplatin/ifosfamide/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 151 - 151
[30] Ifosfamide/levetiracetamEncephalopathy and lack of efficacy: case report
Reactions Weekly, 2022, 1896 (1) : 238 - 238

← 1 2 3 4 5 →